Apoptosis signaling triggered by the marine alkaloid ascididemin is routed via caspase-2 and JNK to mitochondria

被引:36
作者
Dirsch, VM
Kirschke, SO
Estermeier, M
Steffan, B
Vollmar, AM
机构
[1] Univ Munich, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany
[2] Univ Munich, Dept Chem, D-81377 Munich, Germany
关键词
apoptosis; ascididemin; caspase-2; mitochondria;
D O I
10.1038/sj.onc.1207281
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The marine alkaloid ascididemin (ASC) was shown to exert cytotoxicity even against multidrug-resistant cancer cells. Here, we address the signaling pathways utilized by ASC to trigger apoptosis in Jurkat leukemia T cells. We show that ASC (0.5-20 muM) induces a mitochondrial pathway that requires the activation of the initiator caspase-2 upstream of mitochondria. ASC-triggered apoptosis occurred independent of CD95, but required mitochondrial dysfunction. The activation of caspase-2 was shown to precede the processing of caspase-8, -9 and -3. The specific caspase-2 inhibitor zVDVADfmk abrogated ASC-induced DNA fragmentation almost completely. Overexpression of Bcl-x(L) blocked caspase-8 but not caspase-2 processing. Conversely, caspase-2 inhibition strongly reduced caspase-9 activation. As a possible link between caspase-2 and mitochondrial dysfunction, Bid was found to be cleaved by ASC. In addition, JNK was activated by ASC upstream of mitochondria via reactive oxygen species. The specific JNK inhibitor SP600125 partially inhibited caspase-2 and -9 processing as well as cytochrome c release and DNA fragmentation indicating that JNK contributes to, but is not necessary for ASC-mediated apoptosis. Thus, ASC triggers a pathway in which early activation of caspase-2 provides a possible link between its DNA-damaging activity and the induction of mitochondrial dysfunction. The activation of JNK contributes to this signaling upstream of mitochondria.
引用
收藏
页码:1586 / 1593
页数:8
相关论文
共 38 条
[1]   Ajoene-induced cell death in human promyeloleukemic cells does not require JNK but is amplified by the inhibition of ERK [J].
Antlsperger, DSM ;
Dirsch, VM ;
Ferreira, D ;
Su, JL ;
Kuo, ML ;
Vollmar, AM .
ONCOGENE, 2003, 22 (04) :582-589
[2]   The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs) [J].
Barr, RK ;
Bogoyevitch, MA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (11) :1047-1063
[3]   Cytotoxic signalling by inhibitors of DNA topoisomerase II [J].
Beck, WT ;
Mo, YY ;
Bhat, UG .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2001, 29 :702-703
[4]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[5]  
BONNARD I, 1995, ANTI-CANCER DRUG DES, V10, P333
[6]   1ST SYNTHESIS OF THE BENZO[F]PYRIDO[2',3'/3,4]PYRROLO[2,1-A][2,7]NAPHTHYRIDINE RING-SYSTEM [J].
BRACHER, F .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1993, 30 (01) :157-159
[7]   Apoptotic death sensor: an organelle's alter ego? [J].
Bratton, SB ;
Cohen, GM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (06) :306-315
[8]   Communication -: Superoxide in apoptosis -: Mitochondrial generation triggered by cytochrome c loss [J].
Cai, JY ;
Jones, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11401-11404
[9]   Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells [J].
Dassonneville, L ;
Wattez, N ;
Baldeyrou, B ;
Mahieu, C ;
Lansiaux, A ;
Banaigs, B ;
Bonnard, I ;
Bailly, C .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (04) :527-537
[10]  
Dirsch VM, 2001, CANCER RES, V61, P5817